Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Eliquis scores DVT/PE recommendation in Europe

27.06.2014 / Fierce Pharma

Right now, Eliquis, the new-age clot-fighter from Pfizer and Bristol-Myers Squibb, is in third place in a three-horse race. But as it tries to catch up to rivals Pradaxa and Xarelto–not to mention the $3-billion-per-year sales forecasts analysts slapped on it in its early days–a new recommendation for expanded use in Europe should give it a boost.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: